BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Study Submission and User Account

To enter and edit trials, you must register and create a personal user account. Your user name and password will give you access to the closed area of the portal. There you can enter data on your trial and request its publication. A list of all data entry fields can be found below.

For the DRKS, studies must meet the following requirements:

  • The trial must address a health-related question
  • It must involve human subjects

The exact criteria can be found in the FAQ "Which trials can/should be registered with the DRKS?" There you will also find instructions on how to register your trial prospectively.

Please note that JavaScript must be allowed in the DRKS application to use the closed area.

Study Submission

To register and edit studies

Login

DRKS User Account

Create a personal user account

Create user account

Manual for Study- and User Registration

A detailled explanation of how to set up your user account and record your trials can be found here:

Table of Data Entry Fields

The following table lists the parameters that are collected in the German Clinical Trials Register together with the characteristics of each parameter. It also indicates which data points belong to the WHO dataset and are regularly submitted to the WHO meta registry ICTRP. The table is divided into 6 thematic areas, which are found accordingly in the DRKS application.

Study Description

ParameterCharacteristics/EntryWHO
DRKS-ID[ID] (filled automatically)yes
Date of registration in DRKS[Date] (filled automatically)yes
Type of registration

[Select List] (filled automatically)

  • Prospective
  • Retrospective
yes
Title of the study[Free Text]yes
Acronym/abbreviation of the study[Free Text]yes
URL of the study[Free Text]no
Arm 1[Free Text]yes
Additional arms[Free Text]yes
Primary outcome[Free Text]yes
Secondary outcome[Free Text]yes
Study description in lay language[Free Text]no
Study description in scientific language[Free Text]no

Health condition or problem studied

Code system

[Select List]

  • ICD-10
  • Free text
yes
Code[Free Text] (only, if chosen "ICD-10")yes
Description[Free Text] (only active if "Free text" is selected, otherwise the code specified in the system is entered automatically)yes

Other health condition or problem studied

Code system
See Health condition or problem studiedyes
Healthy volunteers

[Radio button]

  • Yes
  • No
no

 Ethics Vote and Other IDs

ParameterCharacteristics/EntryWHO

Address ethics committee

(leading)

[Checkbox] Privacy notice (not submitted to WHO)

[Select list] Ethics Committee

[Address] (only active if "Other" is selected, otherwise the address in the system is automatically entered)

  • Name ethics committee
  • Street address/PO Box
  • Postal code
  • City
  • Country
  • Phone number (with country code)
  • Fax number (with country code)
  • Email address
  • URL of the institution
yes

Date of ethics committee application

(leading)

[Date]no

Ethics review

(leading)

[Select List]

  • Approved
  • No approval required according to the EC
  • Pending/not yet approved
yes

Date of ethics review

(leading)

[Date]yes

Ethics committee number

(leading)

[Free Text]yes

Approval of ethics committee

(leading)

[File Upload]no

Additional vote or amendment

(leading)

[File Upload]no
Optional other ethics committees

As with lead ethics committee

  • [Address] Address ethics committee
  • [Select List] Ethics review
  • [Date] Date of ethics review
yes
No other identification numbers available[Checkbox]no
Other primary registry ID
  • [Free Text] Registry number
  • [Free Text] Registry name
yes
UTN (Universal Trial Number)[Free Text] IDyes
EudraCT Number[Free Text] IDyes
EUDAMED Number[Free Text] IDyes
Other secondary IDs
  • [Free Text] ID/number/funding number
  • [Free Text] Institution name/funding institution
yes

Study Design

ParameterCharacteristics/EntryWHO
Purpose

[Select List]

  • Treatment
  • Prevention
  • Diagnostics
  • Prognosis
  • Supportive care
  • Screening
  • Health care system
  • Basic research/physiological study
  • Pharmacogenetics
  • Pharmacogenomics
  • Health economics
  • Other
yes
Study type

[Radio Button]

  • Interventional
  • Non-interventional
yes
If study type "Interventional":
Allocation

[Select List]

  • N/A (single arm study)
  • Non-randomized controlled study
  • Randomized controlled study
yes
Assignment

[Select List]

  • Single (group)
  • Parallel
  • Crossover
  • Factorial
  • Other
yes
Mechanism of allocation concealment[Free text]no
Sequence generation[Free text]no
Control

[Select List, multiple choice]

  • Uncontrolled/single arm
  • Placebo
  • Active control (effective treatment of control group)
  • Historical
  • Control group receives no treatment
  • Other
yes
Blinding

[Radio Button]

  • Yes
  • No
yes
Who is blinded?

[Select List, multiple choice]

  • Patient/subject
  • Investigator/therapist
  • Caregiver
  • Assessor
  • Data analyst
yes
Phase

[Select List]

  • Not Applicable
  • 0
  • I
  • I-II
  • II
  • II-III
  • III
  • IV
yes
If study type "Non-interventional":
Retrospective/prospective

[Select List]

  • Retrospective
  • Prospective
  • Both
no
Longitudinal/cross-sectional

[Select List]

  • Longitudinal study
  • Cross-sectional study
no
Study type non-interventional

[Checkboxes]

  • Epidemiological study
  • Patient registry
no

Recruitment Data

ParameterCharacteristics/EntryWHO
Recruitment countries[Select List]yes
Number of study centers

[Radio Button]

  • Monocenter study
  • Multicenter study
no
Recruitment location

[Select List] Type of institution

  • University medical center
  • Medical center
  • Doctor’s practice
  • Other

[Free Text] City

[Free Text] Name of institution (only active if type of institution is not "Doctor’s practice")

no
Recruitment status

[Select List]

  • Recruiting planned
  • Recruiting ongoing
  • Enrolling by invitation
  • Recruiting suspended on temporary hold
  • Recruiting complete, study ongoing
  • Recruiting complete, study complete
  • Recruiting stopped (after recruiting started)
  • Recruiting withdrawn (before recruiting started)
yes
Planned study start date[Date]yes
Actual study start date[Date]yes
Planned study completion date[Date]yes
Actual study completion date[Date]yes
Target sample size[Number]yes
Final sample size[Number]yes
Reason if recruiting stopped or withdrawn[Free text]no
Sex

[Select List]

  • Male
  • Female
  • All
yes
Minimum age

[Number]

[List] Unit

  • Years
  • Months
  • Weeks
  • Days
  • Weeks of pregnancy
[Checkbox] No minimum age
yes
Maximum age

[Number]

[List] Unit

  • Years
  • Months
  • Weeks
  • Days
  • Weeks of pregnancy
[Checkbox] No maximum age
yes
Additional inclusion criteria[Free text]yes
Exclusion criteria[Free text]yes

Contacts

ParameterCharacteristics/EntryWHO
Primary Sponsor

[Address]

  • Institution
  • Academic title
  • First name
  • Last name
  • Street address/PO Box
  • Postal code
  • City
  • Country
  • Phone number (with country code)
  • Fax number (with country code)
  • Email address
  • URL of the institution

[Radio Button] Investigator Sponsored/Initiated Trial (IST/IIT) (not submitted to WHO)

  • Yes
  • No
yes
Principal investigator[Address] see "Primary Sponsor"yes
Contact for scientific queries

[Checkbox] Define contact different from PI

If Checkbox active:

[Address] see "Primary Sponsor"

yes
Contact for public queries

[Checkbox] Define contact different from PI

If Checkbox active:

[Address] see "Primary Sponsor"

yes
Source of monetary or material support

[Checkbox] Privacy notice (not submitted to WHO)

[Address]

  • Institution
  • Street address/PO Box
  • Postal code
  • City
  • Country
  • Phone number (with country code)
  • Fax number (with country code)
  • Email address
  • URL of the institution

 

[Select List] Type of monetary or material support

  • Commercial (pharmaceutical industry, medical engineering industry, etc.)
  • Public funding institutions financed by tax money/Government funding body (German Research Foundation (DFG), Federal Ministry of Education and Research (BMBF), etc.)
  • Private sponsorship (foundations, study societies, etc.)
  • Institutional budget, no external funding (budget of sponsor/PI)
yes
Secondary sponsor (not for German studies)[Address] see "Primary Sponsor"yes
Other addresses and contacts[Address] see "Primary Sponsor"yes

Study Results

ParameterCharacteristics/EntryWHO
Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?

[Radio Button]

  • Yes
  • No
yes
IPD Sharing Plan[Free text]yes
Study protocols

[Free text] Description

[Free text] Add link

[File upload] Attach file

yes
Study abstractsee "Study protocols"no
Other study documentssee "Study protocols"no
Background literaturesee "Study protocols"no
Related DRKS studies

[Free Text] DRKS ID

[Free Text] Description

no
Planned publication[Free text]no

Publications/study results

 Description

see "Study protocols"yes
Date of first publication of study results[Date]yes
DRKS entry published for the first time with results[Date] (assigned by the data management)yes

Basic reporting/result tables

Description

see "Study protocols"yes
Brief summary of results[Free text]yes